
Science · Health
Guinea-Bissau newborn vaccine trial will not proceed, lead researcher says
The proposed study would have delayed hepatitis B vaccination for 7,000 newborns. Its lead researcher says Guinea-Bissau did not grant the approval needed to proceed.
5 min3 sources























